Bioneer has for a long time been a certified provider of RNAscope® technology provided by Advanced Cell Diagnostics, Inc (ACD). RNAscope technology has been extensively used for viral detection, and recently tools have been made available for COVID-19/SARS-CoV-2 research.

The current portfolio includes probes for COVID-19 virus and COVID-19 targets, enabling detection of both pathogen and host transcripts. Moreover, the specific COVID-19 immune response can be visualized by detection of individual immunological markers.

If you are currently involved in COVID-19 research, and need a capable research partner to perform your histological expression analysis in fixed infected tissues, biopsies or cytological samples (e.g. paraffin samples), Bioneer is ready and able to assist. By using our available detection technologies, we can analyze both COVID-19 and the known involved host genes. At the moment ACD has developed RNAscope probes for mRNAs encoding SARS-CoV-2 Spike protein and host ACE2 receptor as well as host proteases that are involved in the COVID-19 infection pathway.

Please contact Bioneer’s histology specialist Boye Schnack Nielsen (email), if you are interested in our COVID-19 services.

More information about Bioneer’s molecular histology capabilities can be found here.

Share this post